FOXQ1 and colon adenocarcinoma: In addition, FOXQ1 expression affected the tumor progression of bladder urothelial carcinoma, skin cutaneous melanoma, colon adenocarcinoma, thyroid carcinoma, and testicular germ cell tumors and regulated the differentiation degree of tumor cells in bladder urothelial carcinoma, stomach adenocarcinoma, uterine corpus endometrial carcinoma, brain lower-grade glioma, and liver hepatocellular carcinoma.